4T1(小鼠乳腺癌细胞)

https://789.bio/ec/W10C4O
  • https://789.bio/ec/W10C4O
  • https://789.bio/ec/xeDK44
  • https://789.bio/ec/aqLKKK
  • https://789.bio/ec/GZPxaP
  • https://789.bio/ec/D88pWD
  • https://789.bio/ec/e9ta1C
  • https://789.bio/ec/HKhyaS

货号: CL-0007

Price: ¥1600 ¥1600

Size:
1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]

产品信息

产品名称 4T1(小鼠乳腺癌细胞)
别称 4T1-A
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40% FBS+5% DMSO
温度:液氮
培养方案A(默认) 生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃
培养方案B(可选) 生长培养基:
培养条件: 气相:, 温度:37℃
推荐传代比例 1:3-1:6
推荐换液频率 2-3次/周

参考资料(来源文献)

背景描述 4T1细胞是从410.4瘤株中未经诱变筛得的6-硫鸟嘌噙抗性细胞株。当4T1细胞注射到BALB/c小鼠中时,4T1细胞会自发产生高转移肿瘤,可转移到肺、肝、淋巴结和大脑,同时在注射部位形成始发灶,诱导转移时不需要摘除始发灶。4T1细胞在BALB/c小鼠中的生长与转移特性与人体中的乳腺癌十分相近,这种肿瘤是人Ⅵ期乳腺癌的动物模型。4T1细胞诱导的肿瘤在手术后及未手术情况下转移的动力学相近,可以用作手术后及未手术模型。4T1细胞诱导的肿瘤模型跟其他肿瘤模型相比,由于4T1细胞的抗6-硫鸟嘌噙特性,微小的转移细胞团(少到仅仅1个)也可以在许多远端器官中检测到,没必要数淋巴结或称重器官。
年龄(性别) Female
组织来源 乳腺组织
细胞类型 肿瘤细胞
肿瘤类型 乳腺癌细胞
生物安全等级 BSL-1
致瘤性 Yes, forms tumors and metastasizes in BALB/c mice.

STR位点信息

STR鉴定图

  • Preparation of hesperetin-polyvinylpyrrolidone sub-microparticles by supercritical anti-solvent technique for improved anti-cancer efficiency(2025)

    作者:Xiao-Chang Lu, Biao-Qi Chen, Sheng-Qing Li, Jian-Fei Xu, Ranjith Kumar Kankala, Shi-Bin Wang, Ai-Zheng Chen

    期刊:JOURNAL OF SUPERCRITICAL FLUIDS

    DOI:10.1016/j.supflu.2025.106523

    影响因子:3.4

    引用产品: 4T1 细胞

  • Preparation of Ca-Mg Double-Doped Mesoporous Silica Nanoparticles and Their Drug-Loading and Drug-Releasing Properties(2025)

    作者:Qian Zhang, Jiamin Huang, Chao Liu, Ruihua Chen, Tao Jiang, Yusufu Hailili, Telieke Bahetibieke, Xiaohui Tang, Mei Wang

    期刊:Inorganics

    DOI:10.3390/inorganics13010012

    影响因子:3.1

    引用产品: 4T1 细胞

  • NIR-Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy(2024)

    作者:Ziwei Hu, Haixin Tan, Yicheng Ye, Wenxin Xu, Junbin Gao, Lu Liu, Lishan Zhang, Jiamiao Jiang, Hao Tian, Fei Peng, Yingfeng Tu

    期刊:ADVANCED MATERIALS

    DOI:10.1002/adma.202412227

    影响因子:27.4

    引用产品: NIH/3T3 细胞, 4T1 细胞

  • Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria(2024)

    作者:Linfu Chen, Jingjing Shen, Zheyu Kang, Zemin Zhang, Zixuan Zheng, Lin Zhang, Zhisheng Xiao, Qiang Zhang, Huapan Fang, Jun Zhou, Yudong Wang, Yang Yang, Zhuang Liu, Qian Chen

    期刊:Chem

    DOI:10.1016/j.chempr.2024.01.030

    影响因子:23.5

    引用产品: 4T1 细胞, MCF7 [MCF-7] 细胞, MDA-MB-231 细胞, DMEM高糖 培养基, RPMI-1640 培养基

  • Light-activated polymeric crosslinked nanocarriers as a checkpoint blockade immunoregulatory platform for synergistic tumor therapy(2024)

    作者:Yao Yang, Xiaotong Liang, Qimanguli Saiding, Jiachan Lin, Jinyuan Li, Wenyan Wang, Ping Huang, Li Huang, Wenfeng Zeng, Jinhai Huang, Hongzhong Chen, Wei Tao, Xiaowei Zeng

    期刊:Materials Today

    DOI:10.1016/j.mattod.2024.07.012

    影响因子:21.1

    引用产品: 4T1 细胞, B16 细胞

  • Cu+/Ca2+ Dual-Overload Strategy Assisted by Metabolic-Symbiotic-Destruction for Tumor Apoptosis and Tumor Immune Activation(2024)

    作者:Jiahui Yan, Haoyu Chen, Carlos F. Guimar?es, Rui L. Reis, Zhihua Zhu, Tianyi Wang, Fenglan Zhang, Yaqian Lv, Qihui Zhou, Xiaoying Kong, Jinsheng Shi

    期刊:ADVANCED FUNCTIONAL MATERIALS

    DOI:10.1002/adfm.202403245

    影响因子:19.0

    引用产品: 4T1 细胞, MCF 10A 细胞

  • Structural engineering of magnetite nanozymes for enhanced chemodynamic cancer therapy(2024)

    作者:Yong Qian, Jinglu Zou, Jiahui Zhang, Xingyu Wang, Xiangfu Meng, Yefeng Lin, Wenchu Lin, Miqin Zhang, Hui Wang

    期刊:CHEMICAL ENGINEERING JOURNAL

    DOI:10.1016/j.cej.2024.151867

    影响因子:15.1

    引用产品: 4T1 细胞

  • Mn-CaCO3-based nanosystem for augmented sonodynamic-chemodynamic immunotherapy via PI3K/Akt signaling pathway(2024)

    作者:Mashiti Sha, Huansong Li, Yangsui Liu, Cong Tang, Xue Bai, Yun Wang, Bo Yuan, Kairui Liu, Xiaoning Gao, Jun Yan, Silong Wei, Jin Chang, Jun Kang

    期刊:CHEMICAL ENGINEERING JOURNAL

    DOI:10.1016/j.cej.2024.149450

    影响因子:15.1

    引用产品: 4T1 细胞, B16-F10 细胞

  • Cancer cell membrane proteins-encapsulated nanovaccine enhances cancer immunotherapy and prevention by provoking antigen-specific cellular immunity via the dendritic cell-targeted delivery(2024)

    作者:Xingyu Luo, Xiaolu Chen, Rongying Ma, Zhaoming Fu, Zuwei Liu, Qianhong Su, Huiling Fu, Yong Yang, Wei Xue

    期刊:CHEMICAL ENGINEERING JOURNAL

    DOI:10.1016/j.cej.2024.148611

    影响因子:15.1

    引用产品: DC2.4 细胞, 4T1 细胞

  • Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition(2024)

    作者:Zhou Minglu, Liu Chendong, Li Bo, Li Junlin, Zhang Ping, Huang Yuan, Li Lian

    期刊:Nature Communications

    DOI:10.1038/s41467-024-47111-z

    影响因子:14.7

    引用产品: 4T1 细胞

  • Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?

    部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图

联系我们

400-999-2100

24小时服务热线

sales@procell.com.cn

销售邮箱

×
微信客服 联系我们 返回顶部
在线咨询